Britain faces the ups and downs of first mover status on Covid-19 vaccine
The UK's medicines regulator has now specifically warned that anyone with a history of anaphylaxis should not take the Pfizer-BioNTech vaccine
11 December 2020 - 11:22
London — Britain hailed “V-Day” when it became the first country to roll out the Pfizer-BioNTech Covid-19 vaccine. Yet, as first mover, it has also become the first to report cases of adverse reactions, allowing other nations to watch and learn.
Officials from around the world are keen for British authorities to give them as much information as possible about the two reported cases of anaphylaxis among thousands of people inoculated since mass-vaccination began on Tuesday...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.